You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Characterization of INCB086550, a potent and novel small-molecule PD-L1 inhibitorSmall-molecule PD-L1 inhibitor alternative to mAbs
|
---|---|
Published in |
Cancer Discovery, March 2022
|
DOI | 10.1158/2159-8290.cd-21-1156 |
Pubmed ID | |
Authors |
Holly K. Koblish, Liangxing Wu, Liang-Chuan S. Wang, Phillip C.C. Liu, Richard Wynn, Jonathan Rios-Doria, Susan Spitz, Hao Liu, Alla Volgina, Nina Zolotarjova, Kanishk Kapilashrami, Elham Behshad, Maryanne Covington, Yan-ou Yang, Jingwei Li, Sharon Diamond, Maxim Soloviev, Kevin O'Hayer, Stephen Rubin, Chrysi Kanellopoulou, Gengjie Yang, Mark Rupar, Darlise DiMatteo, Luping Lin, Christina Stevens, Yue Zhang, Pramod Thekkat, Ryan Geschwindt, Cindy Marando, Swamy Yeleswaram, Jeff Jackson, Peggy Scherle, Reid Huber, Wenqing Yao, Gregory Hollis |
X Demographics
The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 13 | 35% |
Spain | 3 | 8% |
Canada | 2 | 5% |
Singapore | 1 | 3% |
Poland | 1 | 3% |
United Kingdom | 1 | 3% |
Guatemala | 1 | 3% |
Mexico | 1 | 3% |
France | 1 | 3% |
Other | 2 | 5% |
Unknown | 11 | 30% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 19 | 51% |
Scientists | 8 | 22% |
Science communicators (journalists, bloggers, editors) | 6 | 16% |
Practitioners (doctors, other healthcare professionals) | 4 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 47 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 19% |
Other | 5 | 11% |
Student > Master | 4 | 9% |
Student > Bachelor | 3 | 6% |
Student > Doctoral Student | 2 | 4% |
Other | 6 | 13% |
Unknown | 18 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 9 | 19% |
Agricultural and Biological Sciences | 4 | 9% |
Medicine and Dentistry | 4 | 9% |
Chemistry | 4 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 6 | 13% |
Unknown | 18 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 August 2022.
All research outputs
#1,885,085
of 24,526,614 outputs
Outputs from Cancer Discovery
#857
of 3,920 outputs
Outputs of similar age
#44,473
of 432,694 outputs
Outputs of similar age from Cancer Discovery
#50
of 128 outputs
Altmetric has tracked 24,526,614 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,920 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.